Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q2 2026 Earnings Call Transcript

Operator Welcome to Fisher & Paykel Healthcare’s Results Conference Call. My name is Lisa, and I’ll be your operator for today’s call. [Operator Instructions] Please note, this conference call is being recorded. I’d now like to turn the call over to Marcus Driller, VP Corporate. Marcus Driller Vice President of Corporate Thank you, Lisa. Well, good morning, everyone, and welcome to the conference call for Fisher & Paykel Healthcare’s First Half Results for the 2026 financial year. On the call today are Lewis Gradon, Managing Director and Chief Executive Officer; Lyndal York, Chief Financial Officer; Andy Niccol, Chief Operating Officer; Justin Callahan, VP, Sales and Marketing; and Andrew Somervell, VP of Products and Technology. Lewis and Lyndal will first provide an overview of the results, and then we’ll move on to questions. We’ll be discussing our results for the 6 months ended 30 September 2025. Earlier today, we provided our 2026 interim report, including financial statements and commentary on our results to the NZX and ASX. These disclosures can be accessed on our website. With that, I’d now like to turn the call over to Lewis.
https://seekingalpha.com/article/4847678-fisher-and-paykel-healthcare-corporation-limited-fspkf-q2-2026-earnings-call-transcript?source=feed_all_articles